| Sector |
Miscellaneous
|
Compare with Sector peers |
| Industry |
Miscellaneous
|
Compare with Industry peers |
| Website | http://www.ptlenterprise.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 333.59 Cr. | |
| Earnings per share (EPS) | 5.39 | Trailing Twelve Months Ending 2021-06 |
| Price-Earning Ratio (PE) | 9.35 | Trailing Twelve Months Ending 2021-06 |
| Industry PE | 114.86 | Trailing Twelve Months Ending 2021-06 |
| Book Value / Share | 46.73 | Trailing Twelve Months Ending 2021-06 |
| Price to Book Value | 1.08 | Calculated using Price: 50.40 |
| Dividend Yield | 9.92 | Period Ending 2021-03 |
| No. of Shares Subscribed | 6.62 Cr. | 66,188,500 Shares |
| FaceValue | 2 | |
| Company Profile | ||
|
PTL Enterprises was incorporated in the year 1959. The group's principal activity is to manufacture tyres. The company operates in three segments; namely lease of plant, health care and other corporation. The company plant is located Kalamassery, Alwaye, Kerala 683104. It has given the plant on lease to Apollo Tyres, which manufactures truck and bus tyres sold under brand name ‘Apollo’. PTL Enterprises manages subsidiaries viz. Artemis Health Sciences Private Limited, Artemis Medicare Services Private Limited, Artemis Life Sciences Private Limited, Artemis Mediequipments Private Limited and Artemis Medical Institute & Hospitals Private Limited. It subsidiary Artemis Medicare Services Private Limited has set up Artemis Health Institute (AHI) a state-of-the-art, super-speciality hospital in Gurgaon. It is a tertiary care hospital with super-specialisation in oncology (cancer), cardiology, cardiovascular surgery, orthopaedics and minimally invasive surgery and offers high-end care in all other areas of medicine. It is one of the country's technologically most advanced hospitals and houses state-of-the-art imaging equipment including PET-CT Fusion Imaging, 64 Slice CT Angiography and IGRT Machine for all the specialties. Artemis Health Institute has been awarded the 'Best IT enabled hospital' award for the year 2008. The subsidiary company is exploring various possibilities in R&D business and partnership with the government for better healthcare. Its registered office is located at 6th floor, Cherupushpam building, Shanmugham Road, Kochi 682031 (Kerala). |
||
Company Profile
PTL Enterprises was incorporated in the year 1959. The group's principal activity is to manufacture tyres.
The company operates in three segments; namely lease of plant, health care and other corporation. The company plant is located Kalamassery, Alwaye, Kerala 683104. It has given the plant on lease to Apollo Tyres, which manufactures truck and bus tyres sold under brand name ‘Apollo’.
PTL Enterprises manages subsidiaries viz. Artemis Health Sciences Private Limited, Artemis Medicare Services Private Limited, Artemis Life Sciences Private Limited, Artemis Mediequipments Private Limited and Artemis Medical Institute & Hospitals Private Limited.
It subsidiary Artemis Medicare Services Private Limited has set up Artemis Health Institute (AHI) a state-of-the-art, super-speciality hospital in Gurgaon. It is a tertiary care hospital with super-specialisation in oncology (cancer), cardiology, cardiovascular surgery, orthopaedics and minimally invasive surgery and offers high-end care in all other areas of medicine. It is one of the country's technologically most advanced hospitals and houses state-of-the-art imaging equipment including PET-CT Fusion Imaging, 64 Slice CT Angiography and IGRT Machine for all the specialties.
Artemis Health Institute has been awarded the 'Best IT enabled hospital' award for the year 2008.
The subsidiary company is exploring various possibilities in R&D business and partnership with the government for better healthcare.
Its registered office is located at 6th floor, Cherupushpam building, Shanmugham Road, Kochi 682031 (Kerala).
| 1 Day |
|
-2.33% |
| 1 Week |
|
-4.73% |
| 1 Month |
|
-3.08% |
| 3 Month |
|
+32.28% |
| 6 Month |
|
+14.68% |
| 1 Year |
|
+27.92% |
| 2 Year |
|
+53.19% |
| 5 Year |
|
-57.59% |
| 9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 25.28 | 23.09 | 17.75 | 25.13 | 24.77 | 28.88 | 21.51 | 25.42 | 30.93 | |
| Return on Capital Employed (%) | 26.01 | 25.00 | 22.53 | 35.27 | 40.59 | 42.04 | 32.48 | 34.79 | 36.95 | |
| Return on Assets (%) | 6.82 | 6.58 | 5.31 | 4.22 | 3.79 | 6.51 | 5.31 | 5.38 | 7.66 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 71 | 81 | 88 | 681 | 436 | 472 | 488 | 447 | 595 | |
| Non Curr. Liab. | 74 | 94 | 83 | 63 | 176 | 185 | 325 | 336 | 409 | |
| Curr. Liab. | 111 | 104 | 117 | 118 | 125 | 14 | 17 | 19 | 23 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 257 | 279 | 288 | 861 | 737 | 670 | 830 | 802 | 1,027 | |
| Non Curr. Assets | 189 | 196 | 196 | 758 | 600 | 652 | 828 | 797 | 975 | |
| Curr. Assets | 67 | 82 | 92 | 104 | 137 | 19 | 2 | 5 | 52 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 257 | 279 | 288 | 861 | 737 | 670 | 830 | 802 | 1,027 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 40 | 40 | 40 | 46 | 53 | 60 | 63 | 63 | 63 | |
| Other Income | 2 | 1 | 2 | 1 | 2 | 11 | 3 | 4 | 7 | |
| Total Income | 42 | 41 | 42 | 47 | 56 | 71 | 66 | 67 | 71 | |
| Total Expenditure | -5 | -5 | -9 | -4 | -5 | -4 | -5 | -5 | -6 | |
| PBIDT | 38 | 37 | 32 | 43 | 51 | 68 | 61 | 61 | 65 | |
| Interest | -12 | -9 | -8 | -5 | -3 | -6 | -2 | -2 | -7 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | |
| Taxation | -8 | -9 | -8 | -13 | -16 | -15 | -18 | -14 | -15 | |
| Exceptional Items | 29 | |||||||||
| PAT | 17 | 18 | 15 | 24 | 30 | 46 | 40 | 44 | 70 |
| Particulars | 9 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 20 | 32 | 26 | 65 | 25 | 48 | 42 | 46 | 40 | |
| Cash Fr. Inv. | -3 | 1 | 0 | -5 | -6 | -35 | -43 | -7 | -68 | |
| Cash Fr. Finan. | -20 | -33 | -26 | -62 | -5 | -10 | -16 | -40 | 28 | |
| Net Change | -2 | 0 | 0 | -2 | 14 | 2 | -17 | 0 | 0 | |
| Cash & Cash Eqvt | 2 | 2 | 3 | 1 | 15 | 17 | 1 | 0 | 0 |
|
Thu, 05 Aug 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 33 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations 2015 please find enclosed herewith copy of notice published in the following newspaper: |
|
Wed, 04 Aug 2021
Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th August 2021 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing regulations) we wish to inform you that Board of Directors of the Company in their meeting held on 4th August 2021 have inter alia approved the Unaudited Financial Results for the quarter ended June 30 2021 as recommended by the Audit Committee |
|
Wed, 04 Aug 2021
Outcome Of The Board Meeting Held On 4Th August 2021 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing regulations) we wish to inform you that Board of Directors of the Company in their meeting held on 4th August 2021 have inter alia approved the Unaudited Financial Results for the quarter ended June 30 2021 as recommended by the Audit Committee. |
| Thu, 05 Aug 2021 |
Close Crossing Last Week Low
|
Opening at High
|
Closing Below Previous Low
|
Making Lower Lows for 3 days
|
Close Within 52 Week High Zone
|
Equities
M.F.
Sectors